The main purpose of this study is to examine: (1) The dynamic changes in cost containment and quality that have occurred under the National Health Insurance (NHI) program in Taiwan; (2) The trade-off effect relationship between cost and quality. This paper uses an empirical model to look at data...

The aim of our paper is to analyse the effect of the so-called performance volume limit (PVL) financing method on acute hospital care.

We study health care premium subsidies in the Swiss cantons in order to understand the reasons behind the substantial cross-cantonal variation in households' premium load, i.e., the share of disposable income that is spent on premiums after the subsidy. Cantons' financial situation is of...

The paper assesses the impact of urbanization on the quality related outcomes of social health insurance systems in 85 Russian regions in 2000-2006. The results of parametric and kernel regressions reveal that controlling for regional income is a significant determinant of infant and under-five...

The 1991 law ‘On health insurance for the citizens of the Russian Federation’ established that social health insurance is to be offered by multiple private insurance companies. The paper is the first econometric analysis measuring the effect of private health insurers on quality related...

Universal Health Coverage is a powerful framework for a nation aiming to protect their population against health risks. However, countries face multiple challenges in implementing, achieving and sustaining UHC strategies. Sharing and learning from diverse country experiences may enable to foster...

Cost containment in pharmaceutical benefits plans is often controversial because of its potential for unintended effects on health and overall expenditures. Thorough evaluations are needed to support benefits plans in developing evidence-based policies. Evaluations of income-based deductibles...

Disease management has been marketed by healthcare industry providers as a way of improving resource allocation in healthcare and containing costs. However, to achieve improved efficiency in healthcare requires the guidelines and protocols in the disease management process to be based on sound...

The American healthcare market is currently estimated at more than $US900 billion with double digit rising costs per year. Psychotropic agent costs have more than kept pace with market increases. Medication acquisition costs are an obvious focus for limiting costs in various care systems....